Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery

Lancet. 2003 Nov 8;362(9395):1582-3. doi: 10.1016/S0140-6736(03)14753-8.

Authors

Alexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, Michael R Lassen

PMID: 14615120
DOI: 10.1016/S0140-6736(03)14753-8

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Clinical Trials as Topic / standards
Drug Industry / economics
Drug Industry / ethics
Fibrinolytic Agents / therapeutic use*
Fondaparinux
Humans
Orthopedic Procedures* / adverse effects
Polysaccharides / therapeutic use*
Postoperative Complications / prevention & control*
Research Design / standards
Research Support as Topic / ethics
Research Support as Topic / standards
Thromboembolism / etiology
Thromboembolism / prevention & control*
Venous Thrombosis / etiology
Venous Thrombosis / prevention & control*

Substances

Fibrinolytic Agents
Polysaccharides
Fondaparinux